Report Categories Report Categories

Report Categories

industry Category

All

Total: 2 records, 1 pages

Global Short Bowel Syndrome (SBS) Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Short Bowel Syndrome (SBS) Drugs

According to our (Global Info Research) latest study, the global Short Bowel Syndrome (SBS) Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global Short Bowel Syndrome (SBS) Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 04 Jan 2023

date Pharma & Healthcare

new_biaoQian Short Bowel Syndrome (SBS) Drugs

Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.

USD3480.00

Add To Cart

Add To Cart

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Short Bowel Syndrome (SBS) Drugs

According to our (Global Info Research) latest study, the global Short Bowel Syndrome (SBS) Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

industry 04 Jan 2023

industry Pharma & Healthcare

new_biaoQian Short Bowel Syndrome (SBS) Drugs

Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.

USD3480.00

addToCart

Add To Cart